Matinas BioPharma Strikes Merger Agreement With GH Power To Form New NYSE-Listed Entity GH Power International; Signs $4M Deal To Sell Its Matinas BioPharma Nanotechnologies To Azurity Pharmaceuticals

Loading news article.

Matinas BioPharma Strikes Merger Agreement With GH Power To Form New NYSE-Listed Entity GH Power International; Signs $4M Deal To Sell Its Matinas BioPharma Nanotechnologies To Azurity Pharmaceuticals | WAPE

Matinas BioPharma Strikes Merger Agreement With GH Power To Form New NYSE-Listed Entity GH Power International; Signs $4M Deal To Sell Its Matinas BioPharma Nanotechnologies To Azurity Pharmaceuticals

Article summary

Related companies

Comments —